Yazar "Boz, C." için listeleme
-
Methylprednisolone concentration in milk and serum during and shortly after IV pulse therapy in patients with MS
Boz, C.; Ozer, B.; Terzi, M.; Karahan, S. Zengin; Sen, S.; Mavis, M.; Sarac, Y. (Sage Publications Ltd, 2018)… -
NMOBase is a Web-based, global observational registry for an 'orphan' disorder: neuromyelitis optica
Kister, I.; Bacon, T.; Alroughani, R.; Boz, C.; Cristiano, E.; Iuliano, G.; Butzkueven, H. (Sage Publications Ltd, 2014)… -
Outcomes of pregnancy in neuromyelitis optica patients: turkish multicenter study data
Altintas, A.; Uygunoglu, U.; Terzi, M.; Boz, C.; Saip, S.; Koseoglu, M.; Siva, A. (Sage Publications Ltd, 2016)… -
Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
Boz, C.; Ozakbas, S.; Terzi, M.; Turkoglu, R.; Akman, G.; Efendi, H.; Altunrende, B. (Sage Publications Ltd, 2017)… -
Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases
Karahan, S. Zengin; Boz, C.; Saip, S.; Kale, N.; Demirkaya, S.; Celik, Y.; Terzi, M. (Elsevier Sci Ltd, 2019)Susac's Syndrome (SS), which was first described in 1979, is a rare and presumably autoimmune disorder characterized by encephalopathy, hearing loss, and visual disturbance resulting from branch retinal artery occlusion ... -
Susac syndrome: clinical features, laboratory testing and treatment responses of 20 cases
Karahan, S. Z.; Boz, C.; Usta, N. C.; Saip, S.; Kale, N.; Demirkaya, S.; Ozbek, S. E. (Sage Publications Ltd, 2017)… -
Tumefactive demyelinating disease is immunologically different from multiple sclerosis
Boz, C.; Gazioglu, S.; Terzi, M. (Sage Publications Ltd, 2007)…
